Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
4/2024
vol. 126 abstract:
Case report
Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
Agnieszka Nowosielska
1
KLINIKA OCZNA 2024, 126, 4: 195-197
Online publish date: 2024/12/30
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
A 72-year-old male, undergoing aflibercept treatment for wet age-related macular degeneration (AMD) in his left eye, developed a full-thickness macular hole after the second injection of the medication.
The additional emergence of a macular hole caused a sudden deterioration in left eye visual acuity. The patient chose to undergo macular hole surgery in the affected eye. Because of concomitant cataract in the left eye, phacoemulsification of the lens was performed, followed by vitrectomy with removal of the internal limiting membrane (ILM) and SF6 tamponade. The macular hole was successfully closed, leading to an improvement in vision, limited only by the existing macular damage from wet AMD. After the procedure, treatment of wet AMD with aflibercept in the left eye was continued. The follow-up period was four years. During this time, the patient’s visual acuity stayed consistently at a level of 0.2. keywords:
macular hole, vitrectomy, wet AMD, neovascular subretinal membrane, anti-VEGF, aflibercept |
|